Objective To study the clinical effect of CARPI(cascade primed immune cells) cell immunotherapy for triple negative breast cancer(TNBC). Methods 64 TNBC patients were randomly divided into two groups, 32 cases in each group. Control Group received radical surgery and routine adjuvant chemoradiotherapy while Treatment Group received radical surgery and routine adjuvant chemoradiotherapy combined with CAPRI cell immunotherapy. The patients were followed up from August 2011 to February 2016 or death time. The ...